These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 15807890)
1. Medroxyprogesterone improves nocturnal breathing in postmenopausal women with chronic obstructive pulmonary disease. Saaresranta T; Aittokallio T; Utriainen K; Polo O Respir Res; 2005 Apr; 6(1):28. PubMed ID: 15807890 [TBL] [Abstract][Full Text] [Related]
2. Effect of medroxyprogesterone on arterial blood gases, leptin and neuropeptide Y in postmenopausal females. Saaresranta T; Irjala K; Polo O Eur Respir J; 2002 Dec; 20(6):1413-8. PubMed ID: 12503697 [TBL] [Abstract][Full Text] [Related]
3. Respiratory insufficiency in postmenopausal women: sustained improvement of gas exchange with short-term medroxyprogesterone acetate. Saaresranta T; Polo-Kantola P; Irjala K; Helenius H; Polo O Chest; 1999 Jun; 115(6):1581-7. PubMed ID: 10378552 [TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep. Saaresranta T; Polo-Kantola P; Rauhala E; Polo O Eur Respir J; 2001 Dec; 18(6):989-95. PubMed ID: 11829107 [TBL] [Abstract][Full Text] [Related]
5. Short-term medroxyprogesterone acetate in postmenopausal women with sleep-disordered breathing: a placebo-controlled, randomized, double-blind, parallel-group study. Anttalainen U; Saaresranta T; Vahlberg T; Polo O Menopause; 2014 Apr; 21(4):361-8. PubMed ID: 24253484 [TBL] [Abstract][Full Text] [Related]
6. IGF-I and ventilation after short-term progestin in postmenopausal women with chronic respiratory insufficiency. Saaresranta T; Irjala K; Polo-Kantola P; Helenius H; Polo O Respir Med; 2000 Sep; 94(9):909-16. PubMed ID: 11001085 [TBL] [Abstract][Full Text] [Related]
7. Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Collop NA Chest; 1994 Sep; 106(3):792-9. PubMed ID: 8082361 [TBL] [Abstract][Full Text] [Related]
8. Prolonged endocrine responses to medroxyprogesterone in postmenopausal women with respiratory insufficiency. Saaresranta T; Irjala K; Polo-Kantola P; Helenius H; Polo O Obstet Gynecol; 2000 Aug; 96(2):243-9. PubMed ID: 10908771 [TBL] [Abstract][Full Text] [Related]
9. Impaired oxygenation during sleep in excessive polycythemia of high altitude: improvement with respiratory stimulation. Kryger M; Glas R; Jackson D; McCullough RE; Scoggin C; Grover RF; Weil JV Sleep; 1978 Sep; 1(1):3-17. PubMed ID: 756057 [TBL] [Abstract][Full Text] [Related]
10. Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients. Wagenaar M; Vos PJ; Heijdra YF; Teppema LJ; Folgering HT Eur Respir J; 2002 Nov; 20(5):1130-7. PubMed ID: 12449165 [TBL] [Abstract][Full Text] [Related]
11. Comparison of acetazolamide and medroxyprogesterone as respiratory stimulants in hypercapnic patients with COPD. Wagenaar M; Vos P; Heijdra Y; Teppema L; Folgering H Chest; 2003 May; 123(5):1450-9. PubMed ID: 12740260 [TBL] [Abstract][Full Text] [Related]
12. Sleep quality, carbon dioxide responsiveness and hypoxaemic patterns in nocturnal hypoxaemia due to chronic obstructive pulmonary disease (COPD) without daytime hypoxaemia. Sandek K; Andersson T; Bratel T; Hellström G; Lagerstrand L Respir Med; 1999 Feb; 93(2):79-87. PubMed ID: 10464857 [TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients. Dolly FR; Block AJ Chest; 1983 Oct; 84(4):394-8. PubMed ID: 6617274 [TBL] [Abstract][Full Text] [Related]
14. Effect of medroxyprogesterone on pulmonary arterial pressure, exhaled nitric oxide, ECG and arterial blood gases. Saaresranta T; Uotila P; Saraste M; Irjala K; Hartiala J; Polo O J Intern Med; 2002 May; 251(5):421-8. PubMed ID: 11982742 [TBL] [Abstract][Full Text] [Related]
15. Medroxyprogesterone improves cardiac autonomic control in postmenopausal women with respiratory insufficiency. Virtanen I; Polo O; Saaresranta T; Kuusela T; Polo-Kantola P; Ekholm E Respir Med; 2004 Feb; 98(2):126-33. PubMed ID: 14971875 [TBL] [Abstract][Full Text] [Related]
16. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Cook WR; Benich JJ; Wooten SA Chest; 1989 Aug; 96(2):262-6. PubMed ID: 2526721 [TBL] [Abstract][Full Text] [Related]
17. Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters: A Randomized Clinical Trial. Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE JAMA Netw Open; 2019 Feb; 2(2):e190067. PubMed ID: 30794302 [TBL] [Abstract][Full Text] [Related]
18. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease. Daskalopoulou E; Patakas D; Tsara V; Zoglopitis F; Maniki E Thorax; 1990 Sep; 45(9):666-9. PubMed ID: 2145654 [TBL] [Abstract][Full Text] [Related]
19. Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy. Rogines-Velo MP; Heberle AE; Joffe H Menopause; 2012 Apr; 19(4):471-5. PubMed ID: 22027945 [TBL] [Abstract][Full Text] [Related]
20. Predictive indexes of nocturnal desaturation in COPD patients not treated with long term oxygen therapy. De Angelis G; Sposato B; Mazzei L; Giocondi F; Sbrocca A; Propati A; Gentile J Eur Rev Med Pharmacol Sci; 2001; 5(5-6):173-9. PubMed ID: 12201668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]